EFFECT ON BEHAVIOR IN HUMANS WITH THE ADMINISTRATION OF TARAXEIN
Abstract
Work in progress centered about the isolation of taraxein from the serum of schizophrenic patients and its administration to monkeys and human volunteers is presented. The taraxein was extracted from a variety of schizophrenic patients in 4 institutions and administered on 17 occasions to nonpsychotic human volunteers and on one occasion to a schizophrenic patient in remission. Several additional studies are planned or in progress and we expect that in the near future it will be possible to present considerably more information.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
